Brief: Kalvista Pharmaceuticals Q4 Net Income USD -44.65 Million
Jul 11 (Reuters) - Kalvista Pharmaceuticals Q4 operating expenses USD 48.455 million. * Q4 operating income USD -48.455 million * Q4 basic EPS USD -1.02
Recent news on Kalvista Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 08:36 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy